Unknown

Dataset Information

0

Rapid Delivery of Nanobodies/VHHs into Living Cells via Expressing In Vitro-Transcribed mRNA.


ABSTRACT: Intracellular antigen labeling and manipulation by antibodies have been long-thought goals in the field of cell research and therapy. However, a central limitation for this application is that antibodies are not able to penetrate into the cytosol of living cells. Taking advantages of small sizes and unique structures of the single-domain antibodies, here, we presented a novel approach to rapidly deliver the nanobody/variable domain of heavy chain of heavy-chain antibody (VHH) into living cells via introducing its coding mRNA, which was generated by in vitro transcription. We demonstrated that actin-green fluorescent proteins (GFP) and Golgi-GFP can be recognized by the anti-GFP nanobody/VHH, vimentin can be recognized by the anti-vimentin nanobody/VHH, and histone deacetylase 6 (HDAC6) can be recognized by the anti-HDAC6 nanobody/VHH, respectively. We found that the anti-GFP nanobody expressed via in vitro-transcribed (IVT) mRNA can be detected in 3 h and degraded in 48 h after transfection, whereas the nanobody expressed via plasmid DNA, was not detected until 24 h after transfection. As a result, it is effective in delivering the nanobody through expressing the nanobody/VHH in living cells from its coding mRNA.

SUBMITTER: Zhou X 

PROVIDER: S-EPMC7044678 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid Delivery of Nanobodies/V<sub>H</sub>Hs into Living Cells via Expressing <i>In Vitro</i>-Transcribed mRNA.

Zhou Xuechen X   Hao Rui R   Chen Chen C   Su Zhipeng Z   Zhao Linhong L   Luo Zhuojuan Z   Xie Wei W  

Molecular therapy. Methods & clinical development 20200130


Intracellular antigen labeling and manipulation by antibodies have been long-thought goals in the field of cell research and therapy. However, a central limitation for this application is that antibodies are not able to penetrate into the cytosol of living cells. Taking advantages of small sizes and unique structures of the single-domain antibodies, here, we presented a novel approach to rapidly deliver the nanobody/variable domain of heavy chain of heavy-chain antibody (V<sub>H</sub>H) into liv  ...[more]

Similar Datasets

| S-EPMC9701387 | biostudies-literature
| S-EPMC6158546 | biostudies-literature
| S-EPMC6453504 | biostudies-literature
| S-EPMC1327688 | biostudies-literature
| S-EPMC8523304 | biostudies-literature
| S-EPMC6444222 | biostudies-literature
| S-EPMC6206083 | biostudies-other
| S-EPMC7695830 | biostudies-literature
| S-EPMC7056535 | biostudies-literature
| S-EPMC8025905 | biostudies-literature